治疗迈尔综合征:目标,误解和当前的代理人
Alessandro De Falco1,2,3, Alfonso Manuel D'Alessio1,2,3, Nicola Brunetti-Pierri1,2,3
1Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
概括
迈尔综合征是一种罕见的结缔组织疾病,由SMAD4基因变异引起,导致多个器官系统的渐进性纤维化. 未来的疗法可能会针对TGF-β信号和纤维化,解决当前治疗的局限性.
科学领域:
- 遗传学和分子生物学
- 结合组织疾病 结合组织疾病
- 纤维性疾病 纤维性疾病
背景情况:
- 迈尔综合征 (MYHRS) 是一种罕见的多系统结合组织疾病.
- 它源于SMAD4基因的功能增益变异,这对TGF-β信号传递和细胞外基质至关重要.
- MYHRS呈现出一种进展性纤维化表型,影响骨,心血管,呼吸和整体系统.
研究的目的:
- 审查目前对迈尔综合征的理解.
- 探索可能的未来治疗策略对MYHRS.
- 确定治疗开发临床和生化终点的未满足需求.
主要方法:
- 关于迈尔综合征的文献评论.
- 讨论潜在的治疗点,包括TGF-β抑制剂和抗纤维性药物.
- 分析当前的研究缺口和未来的方向.
主要成果:
- MYHRS的特点是身材矮小,关节收缩,心脏缺陷,小囊狭窄和皮肤变厚.
- 神经发育障碍,如自闭症谱系障碍,也可能发生.
- 尽管经常发生突变,但在MYHRS患者中存在显著的表型变异.
结论:
- 目前对MYHRS的治疗是纯症状的,没有可用的疾病修饰疗法.
- 研究中的疗法包括TGF-β抑制剂,抗纤维菌剂和基因编辑.
- 需要进一步的研究来确定有效治疗评估的临床和生化终点.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Cardiomyopathy V: Interprofessional Care
584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy III: Hypertrophic Cardiomyopathy
618
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Psychosis: Goals of Pharmacotherapy
653
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
653
Cystic Fibrosis: Management
605
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
605
Rheumatic Heart Disease III: Medical Management
469
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
469


